Articles tagged with Chlamydia
Research suggests that home screening kits for Chlamydia, a common sexually transmitted infection, could be a useful tool in preventing lifelong infertility. The study found that men and women aged 18-35 were willing to participate in urine test kits, with higher participation rates among those from Avon than London.
The completed sequencing project provides crucial information on chlamydial infection, the most prevalent STD in the US. The sequenced genome has revealed surface proteins and unique biochemical pathways for developing antibiotics and vaccines against Chlamydia trachomatis.
Researchers have tested a new approach to immunization, using dendritic cells to stimulate immunity in mice. The technique, which uses heat-killed bacteria to sensitize immune cells, has shown promising results in preventing Chlamydia and potentially HIV infections.
A recent study screened over 13,000 female new recruits at the Army's induction center and found a high prevalence of chlamydia infections, particularly among young women.
A study of 13,204 female military recruits found a 9.2% overall prevalence of chlamydial infection, with peak rates among 17-year-olds. Screening programs based on age could identify 95.3% of infected women using DNA amplification tests like LCR assays.
Chlamydia infection can occur without symptoms, highlighting the need for more frequent testing. The study found that over 50% of infected adolescent females tested positive within six months, emphasizing the importance of regular screenings.
A new study found that screening all young women under 30 for Chlamydia trachomatis infection is the most efficient way to identify infected women, reducing infertility and costly medical complications. The test is cost-effective due to its high sensitivity, identifying more infections.
Researchers at UMass Amherst have developed a chlamydia vaccine that could prevent the leading cause of female infertility in the US. The vaccine targets a specific molecule present in all types of chlamydia, overcoming previous challenges in creating a vaccine for this bacterium.
Researchers identified a carbohydrate structure that Chlamydia trachomatis uses to infect cells, leading to the development of a potential preventive agent. The study found that similar carbohydrates can prevent chlamydial infection, paving the way for the creation of anti-adhesive therapies.
Researchers analyzed data from 958 individuals and found equal rates of chlamydial infection in men and women. The study suggests that diagnostic tests using PCR or LCR may be effective in controlling the spread of Chlamydia.